688166 博瑞醫藥
按盤價 
47.450 -0.330 (-0.691%) | 2025/12 - 人民幣(K¥) | 變動 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 1,223,640 | -4.59% | 1,179,518 | 1,017,331 | 1,052,409 | 785,383 | |
| 減：營業總成本 | 1,204,341 | 9.23% | 980,323 | 783,331 | 789,486 | 598,406 | |
| 其中:營業成本 | 601,612 | 10.40% | 521,414 | 376,299 | 460,671 | 353,994 | |
| 財務費用 | 52,225 | 27.66% | 24,140 | 9,800 | 5,740 | 4,713 | |
| 資產減值損失 | (17,498) | -12.26% | (21,490) | (14,649) | (9,396) | (9,395) | |
| 公允價值變動收益 | 13,785 | -341.85% | (520) | (3,395) | 790 | 44 | |
| 投資收益 | (19,321) | 66.08% | (14,741) | 3,957 | 9,231 | 3,547 | |
| 其中：對聯營企業和合營企業的投資收益 | (12,617) | 37.72% | (13,605) | (8,917) | (9,236) | (2,243) | |
| 營業利潤 | 14,664 | -90.85% | 190,244 | 242,155 | 258,991 | 193,064 | |
| 利潤總額 | 13,909 | -91.15% | 188,770 | 242,207 | 257,455 | 191,321 | |
| 減：所得稅費用 | (23,045) | -244.60% | 15,346 | 30,780 | 19,897 | 21,959 | |
| 淨利潤 | 36,954 | -73.84% | 173,424 | 211,427 | 237,558 | 169,362 | |
| 減：非控股權益 | (17,560) | -63.34% | (29,042) | (28,196) | (6,393) | (521) | |
| 股東淨利潤 | 54,515 | -71.18% | 202,466 | 239,623 | 243,951 | 169,882 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.130 | -71.11% | 0.480 | 0.580 | 0.600 | 0.410 | |
| 每股派息 (元) * | 0.016 | -83.33% | 0.096 | 0.114 | 0.120 | 0.084 | |
| 每股淨資產 (元) * | 5.814 | 5.92% | 5.428 | 5.009 | 4.093 | 3.492 | |
| 審計意見 # | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 23/03/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
